GURFEIN BLAKE enters VALION BIO, INC. with 119.98K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 11/10/2021ACC: 0001104659-21-137184
Officer· Chief Scientific Officer
Since Nov 2021
119.98K
Baseline shares
100% direct
119.98K
Direct ownership
1 position
13.02K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned119.98K
Total
119.98K direct119.98K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 119.98K | Direct |
| Total | 119.98K | 119.98K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
7.81K
Shares owned
N/A
Exercise price
0.12
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
5.21K
Shares owned
N/A
Exercise price
0.12
Expiration
—
Exercise window
—
Total
Underlying
13.02K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 0.12 | — | — | 7.81K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 0.12 | — | — | 5.21K | N/A |
| Total | 13.02K | 0.00 | ||||